Serum Prealbumin Levels on Admission as a Prognostic Marker in Stroke Patients Treated with Mechanical Thrombectomy

Abstract

Background: Prealbumin is a marker of malnutrition and inflammation. It has been associated with poor prognosis in cardiovascular disease, but less is known in stroke patients. Our objective was to evaluate the association of prealbumin levels at admission with prognosis in patients with stroke treated with mechanical thrombectomy. Material & Methods: Retrospective study of a prospective database of consecutive patients treated with mechanical thrombectomy. Clinical, radiological and blood parameters including serum prealbumin, and prognostic variables such as respiratory infection, in-hospital mortality, and modified Rankin scale at 3 months were collected. Results: We included 319 patients between 2018-2019. Prealbumin levels were significantly lower in patients older than 80 years, women, patients with a prestroke Rankin score >2, glomerular filtrate rate <60 ml/min and in those with atrial fibrillation. Regarding prognostic variables, prealbumin levels were not associated with respiratory infection. Low prealbumin levels were associated with poor functional prognosis (Rankin score >2), in-hospital mortality and 3-month mortality. In multivariate analysis, prealbumin was an independent risk factor associated with mortality at 3 months, OR 0.92 [0.86-0.98], p = 0.019. Conclusion: Lower prealbumin levels at admission behaved as independent predictor of long-term mortality in patients treated with mechanical thrombectomy. These results should be replicated in other cohorts.

Low transthyretin concentration linked to adverse prognosis in elderly inpatients

“…Similarly, a lower transthyretin concentration at admission in stroke patients is an independent predictor of long-term mortality after mechanical thrombectomy [21] . Additionally, acute heart failure patients with transthyretin concentration ≤ 15mg/dL at discharge have higher 6-month morbidity and mortality [14] .…”

A multi-subgroup predictive model based on clinical parameters and laboratory biomarkers to predict in-hospital outcomes of plasma exchange-centered artificial liver treatment in patients with hepatitis B virus-related acute-on-chronic liver failure

“…Prealbumin is a marker of malnutrition and inflammation. It has been associated with poor prognosis in cardiovascular disease ( López et al., 2022 ), but less is known in HBV-ACLF patients. This study found that lower prealbumin levels after ALSS treatment are independently associated with in-hospital mortality.…”